{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T05:26:28Z","timestamp":1741325188064,"version":"3.38.0"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-025-01190-2","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:13:45Z","timestamp":1740482025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fetal adnexa-derived allogeneic mesenchymal stem cells for cardiac regeneration: the future trend of cell-based therapy for age-related adverse conditions"],"prefix":"10.1007","volume":"38","author":[{"given":"Fazel","family":"Gorjipour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Bohloolighashghaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadjavad","family":"Sotoudeheian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Pazoki Toroudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"1190_CR1","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association. Circulation. 2018;137:e67\u2013492.","journal-title":"Circulation"},{"key":"1190_CR2","first-page":"191","volume-title":"Biomaterials in translational medicine","author":"E Mostafavi","year":"2018","unstructured":"Mostafavi E, Soltantabar P, Webster TJ. Nanotechnology and picotechnology: A new arena for translational medicine\u201d. In: Yang L, Bahaduri S, Webster TJ, editors. Biomaterials in translational medicine. United States: Academic Press-Elsevier; 2018. p. 191\u2013214."},{"issue":"3","key":"1190_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","volume":"6","author":"PA Heidenreich","year":"2013","unstructured":"Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606\u201319.","journal-title":"Circ Heart Fail"},{"key":"1190_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1557\/mrs.2018.182","volume":"43","author":"A Tay","year":"2018","unstructured":"Tay A. Materials meet bioelectrical and-mechanical demands of the heart. MRS Bull. 2018;43:566\u20137.","journal-title":"MRS Bull"},{"key":"1190_CR5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, \u00d4unpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet. 2004;364:937\u201352.","journal-title":"The Lancet"},{"key":"1190_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001699","volume":"11","author":"T Callender","year":"2014","unstructured":"Callender T, Woodward M, Roth G, et al. Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2014;11: e1001699.","journal-title":"PLoS Med"},{"key":"1190_CR7","first-page":"1","volume":"103","author":"CD Fryar","year":"2012","unstructured":"Fryar CD, Chen T, Li X. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999\u20132010. NCHS Data Brief. 2012;103:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"1190_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0117446","volume":"10","author":"H Seo","year":"2015","unstructured":"Seo H, Yoon SJ, Yoon J, et al. Recent trends in economic burden of acute myocardial infarction in South Korea. PLoS ONE. 2015;10: e0117446.","journal-title":"PLoS ONE"},{"issue":"537\u2013552","key":"1190_CR9","first-page":"ix","volume":"91","author":"VL Roger","year":"2007","unstructured":"Roger VL. Epidemiology of myocardial infarction. Med Clin North Am. 2007;91(537\u2013552):ix.","journal-title":"Med Clin North Am"},{"key":"1190_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0735-1097(15)61385-7","volume":"65","author":"S Shanmugasegaram","year":"2015","unstructured":"Shanmugasegaram S, Dai S, Waters C. Incidence and prevalence of acute myocardial infarction in Canada. J Am Coll Cardiol. 2015;65:1385.","journal-title":"J Am Coll Cardiol"},{"key":"1190_CR11","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.cjca.2015.07.735","volume":"31","author":"F Hannah-Shmouni","year":"2015","unstructured":"Hannah-Shmouni F, Seidelmann SB, Sirrs S, et al. The genetic challenges and opportunities in advanced heart failure. Can J Cardiol. 2015;31:1338\u201350.","journal-title":"Can J Cardiol"},{"key":"1190_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/352734","volume":"2015","author":"J Yang","year":"2015","unstructured":"Yang J, Xu WW, Hu SJ. Heart failure: advanced development in genetics and epigenetics. Biomed Res Int. 2015;2015: 352734.","journal-title":"Biomed Res Int"},{"key":"1190_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/HCO.0000000000000160","volume":"30","author":"CD Rau","year":"2015","unstructured":"Rau CD, Lusis AJ, Wang Y. Genetics of common forms of heart failure: challenges and potential solutions. Curr Opin Cardiol. 2015;30:222\u20137.","journal-title":"Curr Opin Cardiol"},{"key":"1190_CR14","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/j.bbadis.2012.12.012","volume":"1832","author":"LR Lopes","year":"2013","unstructured":"Lopes LR, Elliott PM. Genetics of heart failure. Biochim Biophys Acta. 2013;1832:2451\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"1190_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7326\/M14-1651","volume":"162","author":"A Biswas","year":"2015","unstructured":"Biswas A, Oh PI, Faulkner GE, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med. 2015;162:123\u201332.","journal-title":"Ann Intern Med"},{"key":"1190_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h306","volume":"350","author":"S Mayor","year":"2015","unstructured":"Mayor S. Prolonged sitting increases risk of serious illness and death regardless of exercise, study finds. BMJ. 2015;350: h306.","journal-title":"BMJ"},{"key":"1190_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/179791","volume":"2015","author":"ME Rubio-Ruiz","year":"2015","unstructured":"Rubio-Ruiz ME, Peredo-Escarcega AE, Cano-Martinez A, et al. An evolutionary perspective of nutrition and inflammation as mechanisms of cardiovascular disease. Int J Evol Biol. 2015;2015: 179791.","journal-title":"Int J Evol Biol"},{"key":"1190_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.amjmed.2013.12.014","volume":"127","author":"JE Dalen","year":"2014","unstructured":"Dalen JE, Devries S. Diets to prevent coronary heart disease 1957\u20132013: what have we learned? Am J Med. 2014;127:364\u20139.","journal-title":"Am J Med"},{"key":"1190_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11883-015-0511-z","volume":"17","author":"M Sanghavi","year":"2015","unstructured":"Sanghavi M, Gulati M. Sex differences in the pathophysiology, treatment, and outcomes in IHD. Curr Atheroscler Rep. 2015;17:511.","journal-title":"Curr Atheroscler Rep"},{"key":"1190_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/eci.12399","volume":"45","author":"MG van der Meer","year":"2015","unstructured":"van der Meer MG, Nathoe HM, van der Graaf Y, et al. Worse outcome in women with STEMI: a systematic review of prognostic studies. Eur J Clin Invest. 2015;45:226\u201335.","journal-title":"Eur J Clin Invest"},{"key":"1190_CR21","doi-asserted-by":"publisher","first-page":"H1453","DOI":"10.1152\/ajpheart.00554.2015","volume":"309","author":"ZV Varga","year":"2015","unstructured":"Varga ZV, Ferdinandy P, Liaudet L, et al. Drug-induced mitochondrial dysfunction and cardiotoxicity. Am J Physiol Heart Circ Physiol. 2015;309:H1453-1467.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1190_CR22","first-page":"218","volume":"53","author":"E Badila","year":"2015","unstructured":"Badila E, Hostiuc M, Weiss E, et al. Illicit drugs and their impact on cardiovascular pathology. Rom J Intern Med. 2015;53:218\u201325.","journal-title":"Rom J Intern Med"},{"key":"1190_CR23","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/01.CIR.87.3.755","volume":"87","author":"P Gaudron","year":"1993","unstructured":"Gaudron P, Eilles C, Kugler I, et al. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87:755\u201363.","journal-title":"Circulation"},{"key":"1190_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.14503\/THIJ-13-3585","volume":"41","author":"PK Goel","year":"2014","unstructured":"Goel PK, Bhatia T, Kapoor A, et al. Left ventricular remodeling after late revascularization correlates with baseline viability. Tex Heart Inst J. 2014;41:381\u20138.","journal-title":"Tex Heart Inst J"},{"key":"1190_CR25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1472-8206.2003.00188.x","volume":"17","author":"HR Pazoki-Toroudi","year":"2003","unstructured":"Pazoki-Toroudi HR, Hesami A, Vahidi S, et al. The preventive effect of captopril or enalapril on reperfusion injury of the kidney of rats is independent of angiotensin II AT1 receptors. Fundam Clin Pharmacol. 2003;17:595\u20138.","journal-title":"Fundam Clin Pharmacol"},{"key":"1190_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.15171\/jcvtr.2019.06","volume":"11","author":"F Gorjipour","year":"2019","unstructured":"Gorjipour F, Hosseini-Gohari L, Alizadeh Ghavidel A, et al. Mesenchymal stem cells from human amniotic membrane differentiate into cardiomyocytes and endothelial-like cells without improving cardiac function after surgical administration in rat model of chronic heart failure. J Cardiovasc Thorac Res. 2019;11:35\u201342.","journal-title":"J Cardiovasc Thorac Res"},{"key":"1190_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCRESAHA.117.311045","volume":"121","author":"SA Su","year":"2017","unstructured":"Su SA, Yang D, Wu Y, et al. EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-beta\/Smad3 signaling. Circ Res. 2017;121:617\u201327.","journal-title":"Circ Res"},{"key":"1190_CR28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/0267659117691119","volume":"32","author":"F Gorjipour","year":"2017","unstructured":"Gorjipour F, Dehaki MG, Totonchi Z, et al. Inflammatory cytokine response and cardiac troponin I changes in cardiopulmonary bypass using two cardioplegia solutions; del Nido and modified St. Thomas\u2019: a randomized controlled trial. Perfusion. 2017;32:394\u2013402.","journal-title":"Perfusion"},{"issue":"8","key":"1190_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/0267659119842470","volume":"34","author":"F Gorjipour","year":"2019","unstructured":"Gorjipour F, Totonchi Z, Gholampour Dehaki M, et al. Serum levels of interleukin-6, interleukin-8, interleukin-10, and tumor necrosis factor-alpha, renal function biochemical parameters and clinical outcomes in pediatric cardiopulmonary bypass surgery. Perfusion. 2019;34(8):651\u20139.","journal-title":"Perfusion"},{"key":"1190_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/cvr\/cvn335","volume":"81","author":"M Hori","year":"2009","unstructured":"Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res. 2009;81:457\u201364.","journal-title":"Cardiovasc Res"},{"key":"1190_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1472-8206.2009.00743.x","volume":"24","author":"HR Pazoki-Toroudi","year":"2010","unstructured":"Pazoki-Toroudi HR, Ajami M, Habibey R. Pre-medication and renal pre-conditioning: a role for alprazolam, atropine, morphine and promethazine. Fundam Clin Pharmacol. 2010;24:189\u201398.","journal-title":"Fundam Clin Pharmacol"},{"key":"1190_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1472-8206.2012.01066.x","volume":"27","author":"M Ajami","year":"2013","unstructured":"Ajami M, Davoodi SH, Habibey R, et al. Effect of DHA+EPA on oxidative stress and apoptosis induced by ischemia-reperfusion in rat kidneys. Fundam Clin Pharmacol. 2013;27:593\u2013602.","journal-title":"Fundam Clin Pharmacol"},{"key":"1190_CR33","doi-asserted-by":"publisher","first-page":"9452","DOI":"10.1039\/C7TB01689A","volume":"5","author":"H Amani","year":"2017","unstructured":"Amani H, Habibey R, Hajmiresmail SJ, et al. Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries. J Mater Chem B. 2017;5:9452\u201376.","journal-title":"J Mater Chem B"},{"key":"1190_CR34","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3109\/13880209.2016.1150306","volume":"54","author":"N Ghadernezhad","year":"2016","unstructured":"Ghadernezhad N, Khalaj L, Pazoki-Toroudi H, et al. Metformin pretreatment enhanced learning and memory in cerebral forebrain ischaemia: the role of the AMPK\/BDNF\/P70SK signalling pathway. Pharm Biol. 2016;54:2211\u20139.","journal-title":"Pharm Biol"},{"key":"1190_CR35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nrd.2017.106","volume":"16","author":"TJ Cahill","year":"2017","unstructured":"Cahill TJ, Choudhury RP, Riley PR. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nat Rev Drug Discov. 2017;16:699.","journal-title":"Nat Rev Drug Discov"},{"key":"1190_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-021-00722-w","volume":"28","author":"C Piamsiri","year":"2021","unstructured":"Piamsiri C, Maneechote C, Siri-Angkul N, et al. Targeting necroptosis as therapeutic potential in chronic myocardial infarction. J Biomed Sci. 2021;28:1\u201313.","journal-title":"J Biomed Sci"},{"key":"1190_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10741-016-9538-7","volume":"21","author":"J Mar\u00edn-Garc\u00eda","year":"2016","unstructured":"Mar\u00edn-Garc\u00eda J. Cell death in the pathogenesis and progression of heart failure. Heart Fail Rev. 2016;21:117\u201321.","journal-title":"Heart Fail Rev"},{"key":"1190_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1471-4892(01)00032-7","volume":"1","author":"NH Bishopric","year":"2001","unstructured":"Bishopric NH, Andreka P, Slepak T, et al. Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol. 2001;1:141\u201350.","journal-title":"Curr Opin Pharmacol"},{"key":"1190_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-017-1191-y","volume":"15","author":"E Teringova","year":"2017","unstructured":"Teringova E, Tousek P. Apoptosis in ischemic heart disease. J Transl Med. 2017;15:1\u20137.","journal-title":"J Transl Med"},{"doi-asserted-by":"crossref","unstructured":"Sotoudeheian M, Hoseini S and Mirahmadi S-M-S. Understanding the pathophysiology of heart failure with mid-range ejection fraction: a comprehensive narrative review. In: Preprints. Preprints; 2023.","key":"1190_CR40","DOI":"10.20944\/preprints202303.0228.v1"},{"key":"1190_CR41","first-page":"e240","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA guideline for the management of heart failure. A Rep Am Coll Cardiol Found\/Am Heart Assoc Task Force Pract Guidel. 2013;128:e240\u2013327.","journal-title":"A Rep Am Coll Cardiol Found\/Am Heart Assoc Task Force Pract Guidel"},{"key":"1190_CR42","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/CIRCULATIONAHA.111.060830","volume":"125","author":"GC Stewart","year":"2012","unstructured":"Stewart GC, Givertz MM. Mechanical circulatory support for advanced heart failure. Circulation. 2012;125:1304\u201315.","journal-title":"Circulation"},{"key":"1190_CR43","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1253\/circj.CJ-13-0296","volume":"77","author":"Y Toyoda","year":"2013","unstructured":"Toyoda Y, Guy TS, Kashem A. Present status and future perspectives of heart transplantation. Circ J. 2013;77:1097\u2013110.","journal-title":"Circ J"},{"key":"1190_CR44","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nnano.2017.167","volume":"12","author":"M Mahmoudi","year":"2017","unstructured":"Mahmoudi M, Yu M, Serpooshan V, et al. Multiscale technologies for treatment of ischemic cardiomyopathy. Nat Nanotechnol. 2017;12:845.","journal-title":"Nat Nanotechnol"},{"key":"1190_CR45","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1113\/expphysiol.2012.064832","volume":"97","author":"PC Schenkel","year":"2012","unstructured":"Schenkel PC, Tavares AM, Fernandes RO, et al. Time course of hydrogen peroxide-thioredoxin balance and its influence on the intracellular signalling in myocardial infarction. Exp Physiol. 2012;97:741\u20139.","journal-title":"Exp Physiol"},{"key":"1190_CR46","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.2174\/138161208786071227","volume":"14","author":"G Marazzi","year":"2008","unstructured":"Marazzi G, Rosanio S, Caminiti G, et al. The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failure. Curr Pharm Des. 2008;14:2592\u2013604.","journal-title":"Curr Pharm Des"},{"key":"1190_CR47","first-page":"e88","volume":"18","author":"T Vichova","year":"2013","unstructured":"Vichova T, Motovska Z. Oxidative stress: predictive marker for coronary artery disease. Exp Clin Cardiol. 2013;18:e88-91.","journal-title":"Exp Clin Cardiol"},{"key":"1190_CR48","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMra071667","volume":"357","author":"DM Yellon","year":"2007","unstructured":"Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121\u201335.","journal-title":"N Engl J Med"},{"key":"1190_CR49","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/mnfr.201600112","volume":"60","author":"G Javedan","year":"2016","unstructured":"Javedan G, Shidfar F, Davoodi SH, et al. Conjugated linoleic acid rat pretreatment reduces renal damage in ischemia\/reperfusion injury: unraveling antiapoptotic mechanisms and regulation of phosphorylated mammalian target of rapamycin. Mol Nutr Food Res. 2016;60:2665\u201377.","journal-title":"Mol Nutr Food Res"},{"key":"1190_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biochi.2017.08.007","volume":"142","author":"H Amani","year":"2017","unstructured":"Amani H, Ajami M, Maleki SN, et al. Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants. Biochimie. 2017;142:63\u201379.","journal-title":"Biochimie"},{"key":"1190_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"M Bujak","year":"2007","unstructured":"Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res. 2007;74:184\u201395.","journal-title":"Cardiovasc Res"},{"key":"1190_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Investig. 2013;123:92\u2013100.","journal-title":"J Clin Investig"},{"key":"1190_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotech. 2014;32:252\u201360.","journal-title":"Nat Biotech"},{"key":"1190_CR54","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1089\/ars.2012.4849","volume":"18","author":"C Cochain","year":"2013","unstructured":"Cochain C, Channon KM, Silvestre JS. Angiogenesis in the infarcted myocardium. Antioxid Redox Signal. 2013;18:1100\u201313.","journal-title":"Antioxid Redox Signal"},{"key":"1190_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2013-000016","volume":"1","author":"H Zhang","year":"2014","unstructured":"Zhang H, van Olden C, Sweeney D, et al. Blood vessel repair and regeneration in the ischaemic heart. Open Heart. 2014;1: e000016.","journal-title":"Open Heart"},{"key":"1190_CR56","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.5966\/sctm.2015-0032","volume":"4","author":"B Cai","year":"2015","unstructured":"Cai B, Tan X, Zhang Y, et al. Mesenchymal stem cells and cardiomyocytes interplay to prevent myocardial hypertrophy. Stem Cells Transl Med. 2015;4:1425\u201335.","journal-title":"Stem Cells Transl Med"},{"key":"1190_CR57","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11596-012-0031-9","volume":"32","author":"B Zhang","year":"2012","unstructured":"Zhang B, Yang S, Zhang Y, et al. Co-culture of mesenchymal stem cells with umbilical vein endothelial cells under hypoxic condition. J Huazhong Univ Sci Technolog Med Sci. 2012;32:173\u201380.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"1190_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/324014","volume":"2015","author":"F Jiang","year":"2015","unstructured":"Jiang F, Ma J, Liang Y, et al. Amniotic mesenchymal stem cells can enhance angiogenic capacity via MMPs in vitro and in vivo. Biomed Res Int. 2015;2015: 324014.","journal-title":"Biomed Res Int"},{"key":"1190_CR59","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/sj.bjc.6604508","volume":"99","author":"BM Beckermann","year":"2008","unstructured":"Beckermann BM, Kallifatidis G, Groth A, et al. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer. 2008;99:622\u201331.","journal-title":"Br J Cancer"},{"issue":"8","key":"1190_CR60","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1042\/CBI20110183","volume":"36","author":"MS Choudhery","year":"2012","unstructured":"Choudhery MS, Khan M, Mahmood R, et al. Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti-apoptosis capabilities. Cell Biol Int. 2012;36(8):747\u201353.","journal-title":"Cell Biol Int"},{"key":"1190_CR61","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"114","author":"V Karantalis","year":"2014","unstructured":"Karantalis V, DiFede DL, Gerstenblith G, et al. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the prospective randomized study of mesenchymal stem cell therapy in patients undergoing cardiac surgery (PROMETHEUS) trial. Circ Res. 2014;114:1302\u201310.","journal-title":"Circ Res"},{"key":"1190_CR62","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","volume":"13","author":"LR Gao","year":"2015","unstructured":"Gao LR, Chen Y, Zhang NK, et al. Intracoronary infusion of Wharton\u2019s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial. BMC Med. 2015;13:162.","journal-title":"BMC Med"},{"key":"1190_CR63","first-page":"1369","volume":"65","author":"M Bilal","year":"2015","unstructured":"Bilal M, Haseeb A, Sher Khan MA. Intracoronary infusion of Wharton\u2019s jelly-derived mesenchymal stem cells: a novel treatment in patients of acute myocardial infarction. J Pak Med Assoc. 2015;65:1369.","journal-title":"J Pak Med Assoc"},{"key":"1190_CR64","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s10529-014-1589-z","volume":"36","author":"X Wang","year":"2014","unstructured":"Wang X, Xi WC, Wang F. The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction. Biotechnol Lett. 2014;36:2163\u20138.","journal-title":"Biotechnol Lett"},{"key":"1190_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman AW, DiFede DL, Fishman JE, et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA. 2014;311:62\u201373.","journal-title":"JAMA"},{"key":"1190_CR66","doi-asserted-by":"publisher","first-page":"3945403","DOI":"10.1155\/2017\/3945403","volume":"2017","author":"ST Ji","year":"2017","unstructured":"Ji ST, Kim H, Yun J, et al. Promising therapeutic strategies for mesenchymal stem cell-based cardiovascular regeneration: from cell priming to tissue engineering. Stem Cells Int. 2017;2017:3945403.","journal-title":"Stem Cells Int"},{"key":"1190_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12324","author":"W Gu","year":"2017","unstructured":"Gu W, Hong X, Potter C, et al. Mesenchymal stem cells and vascular regeneration. Microcirculation. 2017. https:\/\/doi.org\/10.1111\/micc.12324.","journal-title":"Microcirculation"},{"key":"1190_CR68","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.3390\/ani11082254","volume":"11","author":"E Iacono","year":"2021","unstructured":"Iacono E, Marcoccia R, Merlo B. Current status on canine foetal fluid and adnexa derived mesenchymal stem cells. Animals. 2021;11:2254.","journal-title":"Animals"},{"key":"1190_CR69","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, Shi Y, Galipeau J, et al. Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT\u00ae) mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy. 2019;21:1019\u201324.","journal-title":"Cytotherapy"},{"key":"1190_CR70","first-page":"63","volume":"11","author":"R Hosseinikia","year":"2017","unstructured":"Hosseinikia R, Nikbakht MR, Moghaddam AA, et al. Molecular and cellular interactions of allogenic and autologus mesenchymal stem cells with innate and acquired immunity and their role in regenerative medicine. Int J Hematol Oncol Stem Cell Res. 2017;11:63\u201377.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"1190_CR71","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3727\/096368915X689758","volume":"25","author":"Y Peng","year":"2016","unstructured":"Peng Y, Pan W, Ou Y, et al. Extracardiac-lodged mesenchymal stromal cells propel an inflammatory response against myocardial infarction via paracrine effects. Cell Transpl. 2016;25:929\u201335.","journal-title":"Cell Transpl"},{"issue":"10","key":"1190_CR72","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","volume":"120","author":"D Luger","year":"2017","unstructured":"Luger D, Lipinski MJ, Westman PC, et al. Intravenously-delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy. Circ Res. 2017;120(10):1598\u2013613.","journal-title":"Circ Res"},{"key":"1190_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/602597","volume":"2015","author":"P Rowart","year":"2015","unstructured":"Rowart P, Erpicum P, Detry O, et al. Mesenchymal stromal cell therapy in ischemia\/reperfusion injury. J Immunol Res. 2015;2015: 602597.","journal-title":"J Immunol Res"},{"key":"1190_CR74","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/j.jcyt.2014.01.001","volume":"16","author":"S Abbott","year":"2014","unstructured":"Abbott S, Mackay G, Durdy M, et al. Twenty years of the International Society for Cellular Therapies: the past, present and future of cellular therapy clinical development. Cytotherapy. 2014;16:S112-119.","journal-title":"Cytotherapy"},{"key":"1190_CR75","first-page":"271","volume-title":"Stem cells in veterinary science","author":"V Chandra","year":"2022","unstructured":"Chandra V, Sharma GT. Prospects of mesenchymal stem cell secretome in veterinary regenerative therapy. In: Stem cells in veterinary science. Springer; 2022. p. 271\u201387."},{"key":"1190_CR76","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/157488712802281286","volume":"7","author":"PJ Kim","year":"2012","unstructured":"Kim PJ, Yang PC. Bone marrow cell therapy in clinical trials: a review of the literature. Rev Recent Clin Trials. 2012;7:204\u201313.","journal-title":"Rev Recent Clin Trials"},{"key":"1190_CR77","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/157340308784245748","volume":"4","author":"L Pendyala","year":"2008","unstructured":"Pendyala L, Goodchild T, Gadesam RR, et al. Cellular cardiomyoplasty and cardiac regeneration. Curr Cardiol Rev. 2008;4:72\u201380.","journal-title":"Curr Cardiol Rev"},{"key":"1190_CR78","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/CIRCRESAHA.111.242610","volume":"108","author":"AR Williams","year":"2011","unstructured":"Williams AR, Trachtenberg B, Velazquez DL, et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res. 2011;108:792\u20136.","journal-title":"Circ Res"},{"key":"1190_CR79","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3109\/14653249.2011.574118","volume":"13","author":"SP Chin","year":"2011","unstructured":"Chin SP, Poey AC, Wong CY, et al. Intramyocardial and intracoronary autologous bone marrow-derived mesenchymal stromal cell treatment in chronic severe dilated cardiomyopathy. Cytotherapy. 2011;13:814\u201321.","journal-title":"Cytotherapy"},{"key":"1190_CR80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1479-5876-10-66","volume":"10","author":"JA Miettinen","year":"2012","unstructured":"Miettinen JA, Salonen RJ, Ylitalo K, et al. The effect of bone marrow microenvironment on the functional properties of the therapeutic bone marrow-derived cells in patients with acute myocardial infarction. J Transl Med. 2012;10:66.","journal-title":"J Transl Med"},{"key":"1190_CR81","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijcard.2011.02.035","volume":"159","author":"E Straburzynska-Migaj","year":"2012","unstructured":"Straburzynska-Migaj E, Popiel M, Grajek S, et al. Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of bone marrow stem cells in patients with acute myocardial infarction. Int J Cardiol. 2012;159:134\u20138.","journal-title":"Int J Cardiol"},{"key":"1190_CR82","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.ijcard.2013.01.217","volume":"168","author":"M Lu","year":"2013","unstructured":"Lu M, Liu S, Zheng Z, et al. A pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction. Int J Cardiol. 2013;168:2221\u20137.","journal-title":"Int J Cardiol"},{"key":"1190_CR83","first-page":"467","volume":"10","author":"M Mohyeddin-Bonab","year":"2007","unstructured":"Mohyeddin-Bonab M, Mohamad-Hassani MR, Alimoghaddam K, et al. Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch Iran Med. 2007;10:467\u201373.","journal-title":"Arch Iran Med"},{"key":"1190_CR84","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/ccd.20406","volume":"65","author":"DG Katritsis","year":"2005","unstructured":"Katritsis DG, Sotiropoulou PA, Karvouni E, et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv. 2005;65:321\u20139.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1190_CR85","first-page":"1443","volume":"117","author":"SL Chen","year":"2004","unstructured":"Chen SL, Fang WW, Qian J, et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J (Engl). 2004;117:1443\u20138.","journal-title":"Chin Med J (Engl)"},{"key":"1190_CR86","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","volume":"94","author":"SL Chen","year":"2004","unstructured":"Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92\u20135.","journal-title":"Am J Cardiol"},{"key":"1190_CR87","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1161\/CIRCRESAHA.115.306332","volume":"117","author":"EC Perin","year":"2015","unstructured":"Perin EC, Borow KM, Silva GV, et al. A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure. Circ Res. 2015;117:576\u201384.","journal-title":"Circ Res"},{"key":"1190_CR88","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jcyt.2014.10.009","volume":"17","author":"A Chullikana","year":"2015","unstructured":"Chullikana A, Majumdar AS, Gottipamula S, et al. Randomized, double-blind, phase I\/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction. Cytotherapy. 2015;17:250\u201361.","journal-title":"Cytotherapy"},{"key":"1190_CR89","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.2174\/1381612821666141126100636","volume":"21","author":"X Li","year":"2015","unstructured":"Li X, Hu YD, Guo Y, et al. Safety and efficacy of intracoronary human umbilical cord-derived mesenchymal stem cell treatment for very old patients with coronary chronic total occlusion. Curr Pharm Des. 2015;21:1426\u201332.","journal-title":"Curr Pharm Des"},{"key":"1190_CR90","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s12265-014-9594-0","volume":"7","author":"M Mushtaq","year":"2014","unstructured":"Mushtaq M, DiFede DL, Golpanian S, et al. Rationale and design of the percutaneous stem cell injection delivery effects on neomyogenesis in dilated cardiomyopathy (the POSEIDON-DCM study): a phase I\/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy. J Cardiovasc Transl Res. 2014;7:769\u201380.","journal-title":"J Cardiovasc Transl Res"},{"key":"1190_CR91","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JM Hare","year":"2009","unstructured":"Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277\u201386.","journal-title":"J Am Coll Cardiol"},{"key":"1190_CR92","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbmt.2013.11.001","volume":"20","author":"J Kurtzberg","year":"2014","unstructured":"Kurtzberg J, Prockop S, Teira P, et al. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biol Blood Marrow Transplant. 2014;20:229\u201335.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1190_CR93","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1634\/stemcells.2004-0013","volume":"22","author":"HS Wang","year":"2004","unstructured":"Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton\u2019s jelly of the human umbilical cord. Stem Cells. 2004;22:1330\u20137.","journal-title":"Stem Cells"},{"key":"1190_CR94","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1359\/jbmr.2003.18.4.696","volume":"18","author":"S Shi","year":"2003","unstructured":"Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res. 2003;18:696\u2013704.","journal-title":"J Bone Miner Res"},{"key":"1190_CR95","doi-asserted-by":"publisher","DOI":"10.1186\/1471-213X-7-11","author":"F Alviano","year":"2007","unstructured":"Alviano F, Fossati V, Marchionni C, et al. Term Amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol. 2007. https:\/\/doi.org\/10.1186\/1471-213X-7-11.","journal-title":"BMC Dev Biol"},{"issue":"3","key":"1190_CR96","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jcyt.2012.11.010","volume":"15","author":"MS Choudhery","year":"2013","unstructured":"Choudhery MS, Badowski M, Muise A, et al. Comparison of human adipose and cord tissue derived mesenchymal stem cells. Cytotherapy. 2013;15(3):330\u201343.","journal-title":"Cytotherapy"},{"issue":"12","key":"1190_CR97","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","volume":"13","author":"PA Zuk","year":"2002","unstructured":"Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279\u201395.","journal-title":"Mol Biol Cell"},{"key":"1190_CR98","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1089\/scd.2006.15.49","volume":"15","author":"MJ Hoogduijn","year":"2006","unstructured":"Hoogduijn MJ, Gorjup E, Genever PG. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells Dev. 2006;15:49\u201360.","journal-title":"Stem Cells Dev"},{"issue":"20","key":"1190_CR99","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.3390\/ani12202753","volume":"12","author":"E Iacono","year":"2022","unstructured":"Iacono E, Merlo B. Stem cells in domestic animals: applications in health and production. Animals. 2022;12(20):2753.","journal-title":"Animals"},{"key":"1190_CR100","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4252\/wjsc.v7.i4.681","volume":"7","author":"C Pipino","year":"2015","unstructured":"Pipino C, Pandolfi A. Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potential. World J Stem Cells. 2015;7:681\u201390.","journal-title":"World J Stem Cells"},{"key":"1190_CR101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17:11\u201322.","journal-title":"Cell Stem Cell"},{"key":"1190_CR102","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nri3209","volume":"12","author":"K Le Blanc","year":"2012","unstructured":"Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383\u201396.","journal-title":"Nat Rev Immunol"},{"key":"1190_CR103","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for cellular therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"1190_CR104","first-page":"215","volume":"9","author":"NM King","year":"2008","unstructured":"King NM, Coughlin CN, Furth M. Ethical issues in regenerative medicine. Wake For Intell Prop LJ. 2008;9:215.","journal-title":"Wake For Intell Prop LJ"},{"key":"1190_CR105","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","volume":"9","author":"AI Caplan","year":"2011","unstructured":"Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9:11\u20135.","journal-title":"Cell Stem Cell"},{"key":"1190_CR106","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25:829\u201348.","journal-title":"Cell Transplant"},{"key":"1190_CR107","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43037","author":"GVK Mohan","year":"2023","unstructured":"Mohan GVK, Tirumandyam G, Vemulapalli HS, et al. Mesenchymal stem cell therapy for a better prognosis of heart failure: a systematic review and meta-analysis of randomized controlled trials. Cureus. 2023. https:\/\/doi.org\/10.7759\/cureus.43037.","journal-title":"Cureus"},{"key":"1190_CR108","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","volume":"12","author":"B Parekkadan","year":"2010","unstructured":"Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010;12:87\u2013117.","journal-title":"Annu Rev Biomed Eng"},{"key":"1190_CR109","doi-asserted-by":"crossref","first-page":"A151","DOI":"10.1016\/j.placenta.2009.11.008","volume":"31","author":"H Tsuji","year":"2010","unstructured":"Tsuji H, Miyoshi S, Ikegami Y, et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are imunologically tolerated and transdifferentiated into cardiomyocytes. Placenta. 2010;31:A151.","journal-title":"Placenta"},{"key":"1190_CR110","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/wrr.12911","volume":"29","author":"PD Mankuzhy","year":"2021","unstructured":"Mankuzhy PD, Ramesh ST, Thirupathi Y, et al. The preclinical and clinical implications of fetal adnexa derived mesenchymal stromal cells in wound healing therapy. Wound Repair Regen. 2021;29:347\u201369.","journal-title":"Wound Repair Regen"},{"key":"1190_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-12-8","volume":"12","author":"MS Choudhery","year":"2014","unstructured":"Choudhery MS, Badowski M, Muise A, et al. Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation. J Transl Med. 2014;12:1\u201314.","journal-title":"J Transl Med"},{"key":"1190_CR112","doi-asserted-by":"publisher","first-page":"2152435","DOI":"10.1155\/2016\/2152435","volume":"2016","author":"M Maredziak","year":"2016","unstructured":"Maredziak M, Marycz K, Tomaszewski KA, et al. The influence of aging on the regenerative potential of human adipose derived mesenchymal stem cells. Stem Cells Int. 2016;2016:2152435.","journal-title":"Stem Cells Int"},{"key":"1190_CR113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.arr.2016.07.004","volume":"31","author":"H Pazoki-Toroudi","year":"2016","unstructured":"Pazoki-Toroudi H, Amani H, Ajami M, et al. Targeting mTOR signaling by polyphenols: a new therapeutic target for ageing. Ageing Res Rev. 2016;31:55\u201366.","journal-title":"Ageing Res Rev"},{"key":"1190_CR114","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jbmr.5650110504","volume":"11","author":"RJ Bergman","year":"1996","unstructured":"Bergman RJ, Gazit D, Kahn AJ, et al. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res. 1996;11:568\u201377.","journal-title":"J Bone Miner Res"},{"key":"1190_CR115","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P","volume":"44","author":"C De Bari","year":"2001","unstructured":"De Bari C, Dell\u2019Accio F, Tylzanowski P, et al. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001;44:1928\u201342.","journal-title":"Arthritis Rheum"},{"key":"1190_CR116","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1359\/jbmr.1999.14.7.1115","volume":"14","author":"G D'Ippolito","year":"1999","unstructured":"D\u2019Ippolito G, Schiller PC, Ricordi C, et al. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res. 1999;14:1115\u201322.","journal-title":"J Bone Miner Res"},{"key":"1190_CR117","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0047-6374(03)00088-5","volume":"124","author":"CG Bellows","year":"2003","unstructured":"Bellows CG, Pei W, Jia Y, et al. Proliferation, differentiation and self-renewal of osteoprogenitors in vertebral cell populations from aged and young female rats. Mech Ageing Dev. 2003;124:747\u201357.","journal-title":"Mech Ageing Dev"},{"key":"1190_CR118","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1089\/107632702320934010","volume":"8","author":"SC Mendes","year":"2002","unstructured":"Mendes SC, Tibbe JM, Veenhof M, et al. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng. 2002;8:911\u201320.","journal-title":"Tissue Eng"},{"key":"1190_CR119","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bone.2003.07.005","volume":"33","author":"K Stenderup","year":"2003","unstructured":"Stenderup K, Justesen J, Clausen C, et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33:919\u201326.","journal-title":"Bone"},{"key":"1190_CR120","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/gerona\/62.2.136","volume":"62","author":"H Zheng","year":"2007","unstructured":"Zheng H, Martin JA, Duwayri Y, et al. Impact of aging on rat bone marrow-derived stem cell chondrogenesis. J Gerontol A Biol Sci Med Sci. 2007;62:136\u201348.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1190_CR121","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0301-472X(03)00088-2","volume":"31","author":"G Van Zant","year":"2003","unstructured":"Van Zant G, Liang Y. The role of stem cells in aging. Exp Hematol. 2003;31:659\u201372.","journal-title":"Exp Hematol"},{"key":"1190_CR122","doi-asserted-by":"publisher","first-page":"H2089","DOI":"10.1152\/ajpheart.00019.2005","volume":"289","author":"H Zhang","year":"2005","unstructured":"Zhang H, Fazel S, Tian H, et al. Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am J Physiol Heart Circ Physiol. 2005;289:H2089-2096.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1190_CR123","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jcb.20681","volume":"97","author":"K Mareschi","year":"2006","unstructured":"Mareschi K, Ferrero I, Rustichelli D, et al. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem. 2006;97:744\u201354.","journal-title":"J Cell Biochem"},{"key":"1190_CR124","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1474-9726.2006.00213.x","volume":"5","author":"A Stolzing","year":"2006","unstructured":"Stolzing A, Scutt A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell. 2006;5:213\u201324.","journal-title":"Aging Cell"},{"doi-asserted-by":"crossref","unstructured":"Sotoudeheian M, Hoseini S and Mirahmadi S-M-S. Therapeutic properties of polyphenols affect AMPK molecular pathway in hyperlipidemia. In: Preprints. Preprints; 2023.","key":"1190_CR125","DOI":"10.20944\/preprints202301.0528.v1"},{"key":"1190_CR126","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/srep00067","volume":"1","author":"J Shen","year":"2011","unstructured":"Shen J, Tsai Y-T, DiMarco NM, et al. Transplantation of mesenchymal stem cells from young donors delays aging in mice. Sci Rep. 2011;1:67.","journal-title":"Sci Rep"},{"key":"1190_CR127","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/j.1582-4934.2009.00998.x","volume":"15","author":"M Khan","year":"2011","unstructured":"Khan M, Mohsin S, Khan SN, et al. Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. J Cell Mol Med. 2011;15:1515\u201327.","journal-title":"J Cell Mol Med"},{"key":"1190_CR128","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.onc.1201178","volume":"15","author":"F Zindy","year":"1997","unstructured":"Zindy F, Quelle DE, Roussel MF, et al. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene. 1997;15:203\u201311.","journal-title":"Oncogene"},{"key":"1190_CR129","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1172\/JCI22475","volume":"114","author":"J Krishnamurthy","year":"2004","unstructured":"Krishnamurthy J, Torrice C, Ramsey MR, et al. Ink4a\/Arf expression is a biomarker of aging. J Clin Invest. 2004;114:1299\u2013307.","journal-title":"J Clin Invest"},{"key":"1190_CR130","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92:9363\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1190_CR131","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/stem.1699","volume":"32","author":"M Tome","year":"2014","unstructured":"Tome M, Sepulveda JC, Delgado M, et al. miR-335 correlates with senescence\/aging in human mesenchymal stem cells and inhibits their therapeutic actions through inhibition of AP-1 activity. Stem Cells. 2014;32:2229\u201344.","journal-title":"Stem Cells"},{"key":"1190_CR132","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1073\/pnas.1310972111","volume":"111","author":"P Wang","year":"2014","unstructured":"Wang P, Han L, Shen H, et al. Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation. Proc Natl Acad Sci U S A. 2014;111:7683\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1190_CR133","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1582-4934.2010.01255.x","volume":"15","author":"Z Wen","year":"2011","unstructured":"Wen Z, Zheng S, Zhou C, et al. Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med. 2011;15:1032\u201343.","journal-title":"J Cell Mol Med"},{"key":"1190_CR134","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.yjmcc.2007.11.014","volume":"44","author":"S Jiang","year":"2008","unstructured":"Jiang S, Kh Haider H, Ahmed RP, et al. Transcriptional profiling of young and old mesenchymal stem cells in response to oxygen deprivation and reparability of the infarcted myocardium. J Mol Cell Cardiol. 2008;44:582\u201396.","journal-title":"J Mol Cell Cardiol"},{"key":"1190_CR135","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1582-4934.2011.01303.x","volume":"16","author":"H Ueyama","year":"2012","unstructured":"Ueyama H, Horibe T, Hinotsu S, et al. Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions. J Cell Mol Med. 2012;16:72\u201382.","journal-title":"J Cell Mol Med"},{"key":"1190_CR136","first-page":"109","volume":"14","author":"AA Ramkisoensing","year":"2011","unstructured":"Ramkisoensing AA, Pijnappels DA, Askar SFA, et al. Cardiovascular differentiation potential of human mesenchymal stem cells strongly depends on developmental stage of donor tissue: implications for future vascular medicine. Angiogenesis. 2011;14:109.","journal-title":"Angiogenesis"},{"key":"1190_CR137","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1634\/stemcells.2004-0058","volume":"22","author":"SA Scherjon","year":"2004","unstructured":"Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338\u201345.","journal-title":"Stem Cells"},{"key":"1190_CR138","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/term.40","volume":"1","author":"M Soncini","year":"2007","unstructured":"Soncini M, Vertua E, Gibelli L, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1:296\u2013305.","journal-title":"J Tissue Eng Regen Med"},{"key":"1190_CR139","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1515\/JPM.2003.040","volume":"31","author":"N Ochsenbein-Kolble","year":"2003","unstructured":"Ochsenbein-Kolble N, Bilic G, Hall H, et al. Inducing proliferation of human amnion epithelial and mesenchymal cells for prospective engineering of membrane repair. J Perinat Med. 2003;31:287\u201394.","journal-title":"J Perinat Med"},{"key":"1190_CR140","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10616-012-9441-6","volume":"64","author":"J Bai","year":"2012","unstructured":"Bai J, Wang Y, Liu L, et al. Human amniotic fluid-derived c-kit(+) and c-kit(-) stem cells: growth characteristics and some differentiation potential capacities comparison. Cytotechnology. 2012;64:577\u201389.","journal-title":"Cytotechnology"},{"key":"1190_CR141","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12015-010-9200-z","volume":"7","author":"S Bollini","year":"2011","unstructured":"Bollini S, Pozzobon M, Nobles M, et al. In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Rev Rep. 2011;7:364\u201380.","journal-title":"Stem Cell Rev Rep"},{"key":"1190_CR142","first-page":"890","volume":"30","author":"P Danieli","year":"2009","unstructured":"Danieli P, Cervio E, Ciuffreda C, et al. Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia\/reoxygenation injury. Eur Heart J. 2009;30:890.","journal-title":"Eur Heart J"},{"key":"1190_CR143","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s12015-012-9405-4","volume":"8","author":"A Preitschopf","year":"2012","unstructured":"Preitschopf A, Zwickl H, Li K, et al. Chondrogenic differentiation of amniotic fluid stem cells and their potential for regenerative therapy. Stem Cell Rev Rep. 2012;8:1267\u201374.","journal-title":"Stem Cell Rev Rep"},{"key":"1190_CR144","first-page":"A92","volume":"24","author":"E Garc\u00eda-Navarro","year":"2013","unstructured":"Garc\u00eda-Navarro E, Garc\u00eda-Bernal D, Mu\u00f1oz-Valera MD, et al. Rabbit amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with adipogenic and osteogenic differentiation potential. Hum Gene Ther. 2013;24:A92.","journal-title":"Hum Gene Ther"},{"key":"1190_CR145","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1071\/RDv22n1Ab384","volume":"22","author":"E Iacono","year":"2010","unstructured":"Iacono E, Brunori L, Pirrone A, et al. Isolation of mesenchymal stem cells from Wharton\u2019s Jelly, cord blood, and amniotic fluid in the horse. Reprod Fertil Dev. 2010;22:348\u20139.","journal-title":"Reprod Fertil Dev"},{"key":"1190_CR146","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1530\/REP-10-0408","volume":"143","author":"E Iacono","year":"2012","unstructured":"Iacono E, Brunori L, Pirrone A, et al. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton\u2019s jelly in the horse. Reproduction. 2012;143:455\u201368.","journal-title":"Reproduction"},{"key":"1190_CR147","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/107836","volume":"2012","author":"MG Roubelakis","year":"2012","unstructured":"Roubelakis MG, Trohatou O, Anagnou NP. Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int. 2012;2012: 107836.","journal-title":"Stem Cells Int"},{"key":"1190_CR148","doi-asserted-by":"publisher","first-page":"13975","DOI":"10.1038\/srep13975","volume":"5","author":"C Xie","year":"2015","unstructured":"Xie C, Jin J, Lv X, et al. Anti-aging effect of transplanted amniotic membrane mesenchymal stem cells in a premature aging model of Bmi-1 deficiency. Sci Rep. 2015;5:13975.","journal-title":"Sci Rep"},{"key":"1190_CR149","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI200420800","volume":"113","author":"IK Park","year":"2004","unstructured":"Park IK, Morrison SJ, Clarke MF. Bmi1, stem cells, and senescence regulation. J Clin Invest. 2004;113:175\u20139.","journal-title":"J Clin Invest"},{"key":"1190_CR150","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.gendis.2015.04.001","volume":"2","author":"R Bhattacharya","year":"2015","unstructured":"Bhattacharya R, Mustafi SB, Street M, et al. Bmi-1: at the crossroads of physiological and pathological biology. Genes Dis. 2015;2:225\u201339.","journal-title":"Genes Dis"},{"key":"1190_CR151","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1359\/jbmr.090812","volume":"25","author":"HW Zhang","year":"2010","unstructured":"Zhang HW, Ding J, Jin JL, et al. Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice. J Bone Miner Res. 2010;25:640\u201352.","journal-title":"J Bone Miner Res"},{"key":"1190_CR152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016789","volume":"6","author":"D Zhang","year":"2011","unstructured":"Zhang D, Jiang M, Miao D. Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse. PLoS ONE. 2011;6: e16789.","journal-title":"PLoS ONE"},{"key":"1190_CR153","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/biology12040552","volume":"12","author":"M Jain","year":"2023","unstructured":"Jain M, Singh N, Fatima R, et al. Amniotic fluid mesenchymal stromal cells derived from fetuses with isolated cardiac defects exhibit decreased proliferation and cardiomyogenic potential. Biology. 2023;12:552.","journal-title":"Biology"},{"key":"1190_CR154","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.yjmcc.2006.12.008","volume":"42","author":"A Chiavegato","year":"2007","unstructured":"Chiavegato A, Bollini S, Pozzobon M, et al. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat. J Mol Cell Cardiol. 2007;42:746\u201359.","journal-title":"J Mol Cell Cardiol"},{"key":"1190_CR155","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/MCA.0b013e3283640f00","volume":"24","author":"W Zhang","year":"2013","unstructured":"Zhang W, Liu XC, Yang L, et al. Wharton\u2019s jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction. Coron Artery Dis. 2013;24:549\u201358.","journal-title":"Coron Artery Dis"},{"key":"1190_CR156","first-page":"187","volume":"35","author":"F Gorjipour","year":"2021","unstructured":"Gorjipour F, Hosseini Gohari L, Hajimiresmaiel SJ, et al. amniotic membrane-derived mesenchymal stem cells for heart failure: a systematic review and meta-analysis of the published preclinical studies. Med J Islam Repub Iran. 2021;35:187.","journal-title":"Med J Islam Repub Iran"},{"key":"1190_CR157","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1210\/er.2008-0031","volume":"30","author":"B Lo","year":"2009","unstructured":"Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev. 2009;30:204\u201313.","journal-title":"Endocr Rev"},{"key":"1190_CR158","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/s44319-024-00099-5","volume":"25","author":"T Sawai","year":"2024","unstructured":"Sawai T, Kataoka M. The ethical and legal challenges of human foetal brain tissue-derived organoids: at the intersection of science, ethics, and regulation. EMBO Rep. 2024;25:1700\u20133.","journal-title":"EMBO Rep"},{"key":"1190_CR159","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7150\/ijms.21666","volume":"15","author":"V Volarevic","year":"2018","unstructured":"Volarevic V, Markovic BS, Gazdic M, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15:36.","journal-title":"Int J Med Sci"},{"key":"1190_CR160","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40778-018-0118-8","volume":"4","author":"R Sagar","year":"2018","unstructured":"Sagar R, Walther-Jallow L, David AL, et al. Fetal mesenchymal stromal cells: an opportunity for prenatal cellular therapy. Curr Stem Cell Rep. 2018;4:61\u20138.","journal-title":"Curr Stem Cell Rep"},{"key":"1190_CR161","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12272-012-0202-z","volume":"35","author":"T Yi","year":"2012","unstructured":"Yi T, Song SU. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharmacal Res. 2012;35:213\u201321.","journal-title":"Arch Pharmacal Res"},{"key":"1190_CR162","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/stem.1982","volume":"33","author":"RM Samsonraj","year":"2015","unstructured":"Samsonraj RM, Rai B, Sathiyanathan P, et al. Establishing criteria for human mesenchymal stem cell potency. Stem Cells. 2015;33:1878\u201391.","journal-title":"Stem Cells"},{"key":"1190_CR163","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3109\/14653249.2010.487900","volume":"12","author":"AP Gee","year":"2010","unstructured":"Gee AP, Richman S, Durett A, et al. Multicenter cell processing for cardiovascular regenerative medicine applications: the cardiovascular cell therapy research network (CCTRN) experience. Cytotherapy. 2010;12:684\u201391.","journal-title":"Cytotherapy"},{"key":"1190_CR164","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000326623","volume":"38","author":"CJ Hunt","year":"2011","unstructured":"Hunt CJ. Cryopreservation of human stem cells for clinical application: a review. Transfus Med Hemother. 2011;38:107\u201323.","journal-title":"Transfus Med Hemother"},{"key":"1190_CR165","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cryobiol.2015.07.003","volume":"71","author":"LA Marquez-Curtis","year":"2015","unstructured":"Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, et al. Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects. Cryobiology. 2015;71:181\u201397.","journal-title":"Cryobiology"},{"key":"1190_CR166","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/sj.bmt.1703692","volume":"30","author":"N Matsumoto","year":"2002","unstructured":"Matsumoto N, Yoshizawa H, Kagamu H, et al. Successful liquid storage of peripheral blood stem cells at subzero non-freezing temperature. Bone Marrow Transplant. 2002;30:777\u201384.","journal-title":"Bone Marrow Transplant"},{"key":"1190_CR167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139834","volume":"10","author":"D Pogozhykh","year":"2015","unstructured":"Pogozhykh D, Prokopyuk V, Pogozhykh O, et al. Influence of factors of cryopreservation and hypothermic storage on survival and functional parameters of multipotent stromal cells of placental origin. PLoS ONE. 2015;10: e0139834.","journal-title":"PLoS ONE"},{"key":"1190_CR168","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jcyt.2016.04.005","volume":"18","author":"Z Yuan","year":"2016","unstructured":"Yuan Z, Lourenco Sda S, Sage EK, et al. Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy. Cytotherapy. 2016;18:860\u20139.","journal-title":"Cytotherapy"},{"issue":"10051","key":"1190_CR169","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Pan\u00e9s","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. The Lancet. 2016;388(10051):1281\u201390.","journal-title":"The Lancet"},{"key":"1190_CR170","doi-asserted-by":"publisher","first-page":"11352","DOI":"10.1021\/acs.chemrev.8b00323","volume":"119","author":"MJ Hajipour","year":"2019","unstructured":"Hajipour MJ, Mehrani M, Abbasi SH, et al. Nanoscale technologies for prevention and treatment of heart failure: challenges and opportunities. Chem Rev. 2019;119:11352\u201390.","journal-title":"Chem Rev"},{"key":"1190_CR171","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1208\/s12248-022-00692-3","volume":"24","author":"D Alzate-Correa","year":"2022","unstructured":"Alzate-Correa D, Lawrence W, Salazar-Puerta A, et al. Nanotechnology-driven cell-based therapies in regenerative medicine. AAPS J. 2022;24:43.","journal-title":"AAPS J"},{"key":"1190_CR172","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.actbio.2023.09.011","volume":"171","author":"J Guo","year":"2023","unstructured":"Guo J, Wang H, Li Y, et al. Nanotechnology in coronary heart disease. Acta Biomater. 2023;171:37\u201367.","journal-title":"Acta Biomater"},{"key":"1190_CR173","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fcell.2017.00002","volume":"5","author":"MT Valarmathi","year":"2017","unstructured":"Valarmathi MT, Fuseler JW, Davis JM, et al. A novel human tissue-engineered 3-D functional vascularized cardiac muscle construct. Front Cell Dev Biol. 2017;5:2.","journal-title":"Front Cell Dev Biol"},{"key":"1190_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112150","volume":"209","author":"Y-H Cheng","year":"2022","unstructured":"Cheng Y-H, Cheng S-J, Chen H-H, et al. Development of injectable graphene oxide\/laponite\/gelatin hydrogel containing Wharton\u2019s jelly mesenchymal stem cells for treatment of oxidative stress-damaged cardiomyocytes. Colloids Surf, B: Biointerfaces. 2022;209: 112150.","journal-title":"Colloids Surf, B: Biointerfaces"},{"key":"1190_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119513","volume":"225","author":"G Choe","year":"2019","unstructured":"Choe G, Kim S-W, Park J, et al. Anti-oxidant activity reinforced reduced graphene oxide\/alginate microgels: mesenchymal stem cell encapsulation and regeneration of infarcted hearts. Biomaterials. 2019;225: 119513.","journal-title":"Biomaterials"},{"key":"1190_CR176","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/jbm.b.34000","volume":"106","author":"R Lakshmanan","year":"2018","unstructured":"Lakshmanan R, Maulik N. Development of next generation cardiovascular therapeutics through bio-assisted nanotechnology. J Biomed Mater Res B Appl Biomater. 2018;106:2072\u201383.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"1190_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.686684","volume":"9","author":"J Guo","year":"2021","unstructured":"Guo J, Yang Z, Wang X, et al. Advances in nanomaterials for injured heart repair. Front Bioeng Biotechnol. 2021;9: 686684.","journal-title":"Front Bioeng Biotechnol"},{"key":"1190_CR178","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1016\/j.actbio.2014.03.013","volume":"10","author":"B-J Kang","year":"2014","unstructured":"Kang B-J, Kim H, Lee SK, et al. Umbilical-cord-blood-derived mesenchymal stem cells seeded onto fibronectin-immobilized polycaprolactone nanofiber improve cardiac function. Acta Biomater. 2014;10:3007\u201317.","journal-title":"Acta Biomater"},{"key":"1190_CR179","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1002\/term.2255","volume":"11","author":"E Blondiaux","year":"2017","unstructured":"Blondiaux E, Pidial L, Autret G, et al. Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction. J Tissue Eng Regen Med. 2017;11:3417\u201327.","journal-title":"J Tissue Eng Regen Med"},{"key":"1190_CR180","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3892\/mmr.2016.5212","volume":"14","author":"Y Wang","year":"2016","unstructured":"Wang Y, Li Y, Song L, et al. The transplantation of Akt-overexpressing amniotic fluid-derived mesenchymal stem cells protects the heart against ischemia-reperfusion injury in rabbits. Mol Med Rep. 2016;14:234\u201342.","journal-title":"Mol Med Rep"},{"key":"1190_CR181","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jss.2015.08.022","volume":"200","author":"R Roy","year":"2016","unstructured":"Roy R, Haase T, Ma N, et al. Decellularized amniotic membrane attenuates postinfarct left ventricular remodeling. J Surg Res. 2016;200:409\u201319.","journal-title":"J Surg Res"},{"key":"1190_CR182","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1161\/CIRCRESAHA.116.304668","volume":"116","author":"PJ Kim","year":"2015","unstructured":"Kim PJ, Mahmoudi M, Ge X, et al. Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium. Circ Res. 2015;116:e40\u201350.","journal-title":"Circ Res"},{"key":"1190_CR183","doi-asserted-by":"publisher","first-page":"448","DOI":"10.5966\/sctm.2014-0253","volume":"4","author":"P Danieli","year":"2015","unstructured":"Danieli P, Malpasso G, Ciuffreda MC, et al. Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis. Stem Cells Transl Med. 2015;4:448\u201358.","journal-title":"Stem Cells Transl Med"},{"key":"1190_CR184","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1089\/scd.2013.0119","volume":"22","author":"EC Martinez","year":"2013","unstructured":"Martinez EC, Vu DT, Wang J, et al. Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat hearts. Stem Cells Dev. 2013;22:3087\u201399.","journal-title":"Stem Cells Dev"},{"key":"1190_CR185","doi-asserted-by":"publisher","first-page":"E2088","DOI":"10.1016\/S0735-1097(13)62088-4","volume":"61","author":"SW Kim","year":"2013","unstructured":"Kim SW, Zhang HZ, Hyun KM. Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model. J Am Coll Cardiol. 2013;61:E2088.","journal-title":"J Am Coll Cardiol"},{"key":"1190_CR186","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.ijcard.2013.01.168","volume":"168","author":"C Castellani","year":"2013","unstructured":"Castellani C, Vescovo G, Ravara B, et al. The contribution of stem cell therapy to skeletal muscle remodeling in heart failure. Int J Cardiol. 2013;168:2014\u201321.","journal-title":"Int J Cardiol"},{"key":"1190_CR187","doi-asserted-by":"publisher","first-page":"171","DOI":"10.46582\/jsrm.0803010","volume":"8","author":"M Kimura","year":"2012","unstructured":"Kimura M, Toyoda M, Gojo S, et al. Allogeneic amniotic membrane-derived mesenchymal stromal cell transplantation in a porcine model of chronic myocardial ischemia. J Stem Cells Regen Med. 2012;8:171\u201380.","journal-title":"J Stem Cells Regen Med"},{"key":"1190_CR188","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3727\/096368912X653039","volume":"21","author":"CH Fang","year":"2012","unstructured":"Fang CH, Jin J, Joe JH, et al. In vivo differentiation of human amniotic epithelial cells into cardiomyocyte-like cells and cell transplantation effect on myocardial infarction in rats: comparison with cord blood and adipose tissue-derived mesenchymal stem cells. Cell Transplant. 2012;21:1687\u201396.","journal-title":"Cell Transplant"},{"key":"1190_CR189","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.healun.2011.07.017","volume":"30","author":"A Angelini","year":"2011","unstructured":"Angelini A, Castellani C, Ravara B, et al. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process. J Heart Lung Transplant. 2011;30:1281\u201393.","journal-title":"J Heart Lung Transplant"},{"key":"1190_CR190","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3727\/096368909788809785","volume":"18","author":"KL Fujimoto","year":"2009","unstructured":"Fujimoto KL, Miki T, Liu LJ, et al. Naive rat amnion-derived cell transplantation improved left ventricular function and reduced myocardial scar of postinfarcted heart. Cell Transplant. 2009;18:477\u201386.","journal-title":"Cell Transplant"},{"key":"1190_CR191","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ejcts.2005.07.019","volume":"28","author":"S Sartore","year":"2005","unstructured":"Sartore S, Lenzi M, Angelini A, et al. Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Eur J Cardiothorac Surg. 2005;28:677\u201384.","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01190-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-025-01190-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-025-01190-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T01:43:23Z","timestamp":1741311803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-025-01190-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":191,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1007\/s13577-025-01190-2","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"61"}}